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Copper plays an essential role in processes including
signaling to the transcription and protein trafficking
machinery, oxidative phosphorylation, iron mobiliza-
tion, neuropeptide maturation, and normal develop-
ment. Whereas much is known about intracellular mo-
bilization of ions such as calcium, little information is
available on how eukaryotic cells mobilize intracellular
copper stores. We describe a mechanism by which the
Saccharomyces cerevisiae Ctr2 protein provides bio-
available copper via mobilization of intracellular cop-
per stores. Whereas Ctr2 exhibits structural similarity
to the Ctr1 plasma membrane copper importer, micro-
scopic and biochemical fractionation studies localize
Ctr2 to the vacuole membrane. We demonstrate that
Ctr2 mobilizes vacuolar copper stores in a manner de-
pendent on amino acid residues conserved between the
Ctr1 and Ctr2 copper transport family and that ctr2
mutants hyper-accumulate vacuolar copper. Further-
more, a Ctr2 mutant that is mislocalized to the plasma
membrane stimulates extracellular copper uptake, sup-
porting a direct role for Ctr2 in copper transport across
membranes. These studies identify a novel mechanism
for copper mobilization and suggest that organisms
cope with copper deprivation via the use of intracellular
vesicular stores.
Metal ions such as calcium, copper, iron, and zinc play nu-
merous and diverse roles in cellular physiology. Much is known
about the role of calcium import from extracellular sources and
mobilization from intracellular compartments in signaling pro-
cesses including nutrient sensing (1), stress adaptation (2–4),
cell-cycle control (5, 6), and protein processing in the endoplas-
mic reticulum (7). The mechanism of transcriptional regulation
by calcium signaling via the calmodulin/calcineurin pathway
identified in mammalian cells is conserved in yeast, suggesting
that these signaling mechanisms are common to most organ-
isms (8–10). The need to maintain adequate levels of intracel-
lular calcium, yet keep the cytosolic concentrations of this
second messenger under tight control, demands that much of
the cellular calcium be sequestered until use. In yeast cells the
vacuole possesses more than 95% of the total cellular calcium
(11–13).
The yeast vacuole is an important and dynamic organelle
that is most similar to lysosomes in mammalian cells. Vacuole
function has been shown to be critical for maintenance of in-
tracellular pH, and the vacuole also acts as a storage compart-
ment for amino acids, metal ions, and other molecules (14).
Previous studies suggest that, like calcium, the yeast vacuole is
a significant storage compartment for iron and zinc (15–18).
Specific mechanisms for transport of vacuolar calcium (19–21),
iron (22–25), and zinc (26–28) have been identified and dem-
onstrated to play an important role in the homeostatic regula-
tion of these metals. However, whereas vacuole biogenesis mu-
tants have been demonstrated to be sensitive to copper toxicity
(16, 29), little is known about the mechanisms by which vacu-
oles participate in copper homeostasis to augment copper-de-
pendent signaling or copper-dependent enzyme activities.
Eukaryotes from yeast to humans utilize Ctr11 proteins for
the high affinity transport of Cu(I) across the plasma mem-
brane (30–36). The Ctr1 high affinity copper transporters are
characterized by the presence of three transmembrane do-
mains and a series of methionine residues in both the extra-
cellular amino terminus and the second transmembrane do-
main that are critical for copper transport activity (37).
Intracellular copper is routed to copper-dependent enzymes in
the cytosol such as Cu,Zn-superoxide dismutase, in mitochon-
dria (cytochrome oxidase), and in the secretory pathway (for
example, the Fet3 or ceruloplasmin ferroxidase in yeast and
mammals, respectively) through the action of specific copper
chaperone proteins (38–41). Recent experiments have demon-
strated that S. cerevisiae cells lacking the high affinity plasma
membrane transporters are capable of routing copper to both
Fet3 and Cu,Zn-superoxide dismutase (42). This activity was
shown to be dependent at least in part on the Fet4 plasma
membrane broad-specificity copper, iron, zinc transporter, and
the Ctr2 protein (42). Ctr2 was first identified based on its
strong homology to Copt1, a plant copper transporter that is a
member of the Ctr1 family, and suggested to be a low affinity
copper importer (32). Two reports have localized an epitope-
tagged form of Ctr2 and a Ctr2-GFP fusion protein to the
vacuolar membrane and punctate spots, or the endoplasmic
reticulum, respectively (42, 43). However, the subcellular loca-
tion of Ctr2 has not been firmly established, nor has its role in
copper homeostasis been clearly defined.
Here we demonstrate that S. cerevisiae Ctr2 is localized to
the vacuole membrane where it functions to mobilize vacuolar
copper stores to cytosolic copper chaperones. We show direct
evidence that Ctr2 function affects vacuolar copper levels and
that a CTR2 mutant that suppresses the requirement for the
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high affinity plasma membrane Cu(I) transporters is mislocal-
ized to the plasma membrane and facilitates the kinetics of
copper uptake into cells. Taken together, these studies identify
a mechanism whereby cells mobilize intracellular copper stores
to render this metal available for cellular signaling and a
number of copper-dependent enzymes whose activity is essen-
tial for normal growth and development.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids—The ctr1ctr3ctr2 strain was con-
structed by integrating the HIS3 gene at the CTR2 locus in the MPY17
strain (44). Wild-type CTR2 and CTR2 mutant alleles were amplified
from genomic DNA by PCR. Site-directed mutagenesis was performed
by the overlap extension method (45). For the CTR2-GFP fusion, a NotI
restriction enzyme site was introduced in-frame just upstream of the
stop codon and the GFP open reading frame was inserted. Yeast strains
were transformed with plasmids using standard techniques and grown
in minimal selective media at 30 °C with agitation.
Functional Complementation of ctr2 Mutants—ctr1ctr3ctr2 cells
were transformed with wild-type, mutant CTR2, or empty plasmids and
grown to exponential phase in selective media with agitation. 10-Fold
serial dilutions were spotted on selective media, ethanol (2%) and
glycerol (3%) media (YPEG), and YPEG containing 10, 15, 20, 25, and
100 M copper containing 1.5% agar and incubated for 3–7 days at
30 °C.
Fluorescence Microscopy—The ctr1ctr3ctr2 strain was trans-
formed with p416GPD-CTR2-GFP and grown in selective media to
exponential phase at 30 °C. FM4-64 (Molecular Probes) was added to a
final concentration of 40 M and cells were incubated at 30 °C for 15
min. Cells were then collected and resuspended in fresh media for
further incubation at 30 °C without agitation for 30–60 min. Cells were
visualized with a Zeiss Axioskop upright, wide field fluorescence micro-
scope equipped with a filter wheel. Indirect immunofluorescence was
performed as previously described (46). Polyclonal antibody against
Ctr2 was generated by Bethyl Laboratories, Inc. from a peptide se-
quence (CVHKRQLSQRVLLPNRSLTK) in the intracellular loop region
of Ctr2 and affinity purified.
Vacuole Isolation and ICP-MS—Vacuoles were isolated from sphero-
plasted yeast cells by previously described methods (47). Briefly,
spheroplasts were resuspended in buffer containing PIPES and 15%
Ficoll. DEAE-dextran was added to permeabilize the plasma mem-
brane. Lysates were then loaded into Beckman SW41 ultraclear tubes
and overlaid with the same buffer containing 8 and 4% Ficoll, and then
tubes were filled completely with buffer. Gradients were centrifuged at
30,000 rpm for 1.5 h at 4 °C. Samples were then collected from each of
the three interfaces of the gradients (0/4, 4/8, and 8/15%) and total
protein concentrations were determined using the BCA method. 50 g
of total protein was used for ICP-MS analysis. For ICP-MS analysis,
cells were incubated with 20 M copper for 1 h prior to harvesting the
cells.
Immunoblotting—Whole cell extracts made by the alkali extraction
method (48) or samples from the vacuole isolation were separated by 10
or 15% SDS-PAGE, transferred to nitrocellulose membranes, and
probed with anti-GFP (Chemicon), anti-Pma1 (Santa Cruz), anti-alka-
line phosphatase, anti-3-phosphoglycerate kinase, or anti-carboxypep-
tidase Y (all from Molecular Probes).
Identification of CTR2 Mutants—A PCR-based random mutagenesis
strategy was used to generate CTR2 mutant alleles (49). The CTR2
mutant alleles were cloned into the constitutive GPD promoter-driven
yeast expression vector. Approximately 1  104 expression plasmids
containing CTR2 alleles were generated. This CTR2 expression library
was transformed into ctr1ctr3 cells, and the yeast cells were selected
on YPEG media. Plasmids containing Ctr2 mutant alleles were isolated
from yeast cells growing on YPEG media and sequenced.
Copper Accumulation and 64Cu Uptake—Whole cells were used to
measure copper accumulation and 64Cu uptake. Radioactive 64Cu was
purchased from the Mallinckrodt Institute of Radiology at Washington
University, St. Louis, MO. Copper accumulation was measured by
ICP-MS, and 64Cu was quantified in a Packard Cobra II -counter as
described before (37).
RESULTS
Ctr2 Contributes Copper to Mitochondrial Respiration—All
characterized members of the Ctr1 family of high affinity
plasma membrane copper transporters possess specific con-
served structural features (50), which include three putative
transmembrane domains, the second of which contains a Met-
X3-Met motif required for function (Fig. 1A). Additionally,
many Ctr1 family members identified to date possess a methi-
onine-rich amino terminus and a cysteine/histidine-rich car-
boxyl terminus. Along with these structural features, all Ctr1
family members possess a methionine residue, shown to be
essential for function, 20 amino acids upstream of the first
transmembrane domain (37). Interestingly, Ctr2 has two me-
thionine residues separated by one amino acid in this position.
Whereas S. cerevisiae Ctr2 shares only 23% amino acid iden-
tity overall with Ctr1, the majority of sequence conservation
occurs within the hydrophobic transmembrane domains and
the 20 amino acid residues from the conserved methionine to
the first transmembrane domain. Fig. 1A summarizes the
structural features that are conserved in S. cerevisiae Ctr1,
Ctr2, and potential Ctr2 homologs from Schizosaccharomyces
pombe, mouse, and humans.
Work by Culotta and colleagues demonstrated that ctr2
mutants, in the context of a ctr1ctr3 double mutant back-
ground, exhibited decreased activity of both Cu,Zn-superoxide
dismutase and the Fet3 multicopper ferroxidase that functions
in high affinity iron uptake (42). To further explore the physi-
ological role of Ctr2 in copper homeostasis we ascertained
whether ctr1ctr3ctr2 strains displayed a more pronounced
defect in delivery of copper to mitochondrial cytochrome oxi-
dase than the parental CTR2 strain, as measured by growth on
the non-fermentable carbon sources glycerol and ethanol. As
shown in Fig. 1B, a ctr1ctr3 strain cannot grow on ethanol-
glycerol media (YPEG), as it possesses a defective mitochon-
drial respiratory chain because of the inability of cytochrome c
oxidase to obtain its copper cofactor. The addition of exogenous
copper to the growth medium at concentrations of 15 to 20 M
or higher rescues this phenotype, indicating the mitochondrial
defect is because of a lack of copper and not general mitochon-
drial dysfunction. Deletion of CTR2 in the ctr1ctr3 back-
ground resulted in a more severe respiratory deficiency, with
ctr1ctr3ctr2 cells unable to grow even when supplemented
to 20 M copper, but retaining growth in the presence of 100 M
copper (Fig. 1B). Furthermore, overexpression of the wild type
CTR2 gene or a CTR2-GFP fusion allele restored growth on
YPEG containing 10 M copper. Taken together, these results
suggest that inactivation of CTR2 causes an exacerbated cop-
per deficiency and that increased levels of Ctr2, or a Ctr2-GFP
fusion protein, are beneficial for cell growth under conditions of
copper deprivation.
Ctr2 Is a Vacuolar Membrane Protein—Despite the primary
structural and topological similarities between Ctr2 and the
Ctr1 family and their involvement in copper-dependent physi-
ological processes, Ctr2 cannot complement the growth defect
associated with ctr1ctr3mutants (Fig. 1B) (32, 42). Although
Ctr2 was initially proposed to function as a low affinity copper
importer (32), a partially functional epitope-tagged CTR2 allele
was localized to intracellular membranes that were postulated
to be largely vacuolar (42). Moreover, a genome-wide GFP
fusion analysis placed Ctr2-GFP in the endoplasmic reticulum
(43). To establish Ctr2 subcellular location, the functional Ctr2-
GFP fusion protein was localized both by fluorescence micros-
copy and by vacuolar purification on discontinuous Ficoll den-
sity gradients. As shown in Fig. 2A, ctr2 cells bearing the
CTR2-GFP expression plasmid displayed co-localization of
Ctr2-GFP with the perimeter of the vacuole, as ascertained by
DIC imaging and by overlapping fluorescence with the red
fluorescent lipophilic dye FM4-64, which is endocytosed to the
vacuole membrane. We also observed vacuolar localization of
Ctr2-GFP for a chromosomal CTR2-GFP fusion allele (data not
shown), and this localization did not change in the presence or
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absence of copper or the plasma membrane copper transporters
CTR1 and CTR3 (data not shown).
Based on the microscopic localization of Ctr2-GFP, we inde-
pendently confirmed the vacuolar localization of Ctr2-GFP by
vacuole purification and immunoblotting experiments. The dy-
namic nature of yeast vacuoles allows them to be isolated intact
from whole yeast cells; centrifugation of permeabilized yeast
spheroplasts on a discontinuous density gradient causes the
vacuoles to expand and float to the top, whereas the other
organelles and cellular debris fractionate elsewhere in the gra-
dient. A sample from each interface of the density gradient was
collected and separated by SDS-PAGE, followed by immuno-
blotting to detect Ctr2-GFP. As shown in Fig. 2B, Ctr2-GFP
co-fractionates with the integral vacuolar membrane protein
alkaline phosphatase as well as carboxypeptidase Y, a protein
contained in the lumen of the vacuole. The GFP fusion does not
affect localization of Ctr2, as a non-tagged plasmid-born copy of
Ctr2 shows an identical fractionation pattern (Fig. 6A). 3-Phos-
phoglycerate kinase is a cytosolic protein that does not appear
in the same fraction as Ctr2-GFP, alkaline phosphatase, and
carboxypeptidase Y, indicating the vacuoles have indeed been
purified away from other cellular components. Marker proteins
in the mitochondria (Cox2) and trans-Golgi apparatus (Kex2)
also do not appear in the fraction with the vacuoles (data not
shown). Whereas there is slight contamination of the vacuole
fraction with the plasma membrane ATPase Pma1, there is no
FIG. 1. Ctr2 shares structural and functional features with the Ctr family of copper transporters. A, alignment of Ctr proteins.
S. cerevisiae Ctr2 (ScCtr2) and a mutant allele (ScCtr2-1) share conserved structural features with S. cerevisiae Ctr1 (ScCtr1 and putative
functional homologs from other organisms (S. pombe (Sp) Ctr6 and human (Hs) and mouse (Mm) Ctr2). These features include three transmem-
brane domains (light gray), a conserved methionine residue(s) (M or MXM) approximately 20 amino acids upstream of the first transmembrane
domain, and a Met-X3-Met motif in the second transmembrane domain. Most Ctr family members also possess amino termini rich in methionine
residues (dark gray). Numbers to the right of each protein indicate the length in amino acids. B, Ctr2 contributes copper to mitochondrial
respiration. ctr1ctr3 cells or ctr1ctr3ctr2 cells transformed with vector, CTR2, or CTR2-GFP under the control of the GPD promoter were
spotted onto selective media (Sc-ura) and ethanol-glycerol media (YPEG) with and without copper. Deletion of CTR2 in the ctr1ctr3 background
results in a more severe growth defect that can be rescued by overexpression of wild-type CTR2 and the CTR2-GFP fusion.
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enrichment of the plasma membrane in the vacuole samples
over the other fraction where Pma1 is observed (Fig. 6A). Given
the vast abundance of Pma1 in the plasma membrane, the
actual plasma membrane contamination present in the vacuole
samples is likely very low.2 Together with the results of the
fluorescence microscopy, these biochemical data firmly support
a vacuolar localization for Ctr2.
Ctr2 Mobilizes Vacuolar Copper Stores—Genetic evidence,
subcellular localization studies, and the homology of Ctr2 to
the Ctr1 family of plasma membrane copper transporters are
consistent with the hypothesis that Ctr2 functions in copper
homeostasis by transporting copper across the vacuolar mem-
brane. To date, however, little information is available on the
mobilization of copper from the lumen of internal organelles to
the cytosolic copper chaperones. If Ctr2 functions in the export
of vacuolar copper stores to the cytosol, we reasoned that vac-
uolar copper levels should vary with changes in the levels of
expression or functional state of Ctr2 protein. To test this
hypothesis we quantified vacuolar-associated copper by induc-
tively coupled plasma mass spectrometry (ICP-MS) in an oth-
erwise wild-type ctr2 strain transformed with either an empty
vector or CTR2 under the control of the constitutive GPD
promoter. One hour prior to harvesting cells for the vacuole
purification, cultures were supplemented with 20 M copper,
and vacuoles were isolated as described under “Experimental
Procedures.” The data in Fig. 3, which represent three inde-
pendent experiments, demonstrate that cells lacking CTR2
possess vacuolar copper levels that are 4-fold higher than
cells constitutively expressing CTR2. This same trend was also
observed when cells were supplemented with 100 M copper for
30 min prior to harvesting, and in the ctr1ctr3ctr2 strain
supplemented with 20 M copper prior to harvest (data not
shown). Taken together, these results demonstrate that loss of
CTR2 results in vacuolar copper accumulation, and suggest
that Ctr2 functions during copper deficiency by mobilizing vac-
uolar copper stores from the vacuolar lumen to the cytosol.
Methionine Residues and Multimerization Are Critical for
Ctr2 Function—Much is known about the mechanisms by
which copper transporting P-type ATPases pump copper into
the lumen of the secretory compartment in both yeast and
mammals (51–53). In contrast, little is known about the mech-
anisms by which cells mobilize stores of intracellular copper.
Given the significant primary structural and topological simi-
larity to Ctr1, and the data pointing to a role for Ctr2 in
vacuolar copper mobilization, we carried out structure-function
studies to ascertain whether Ctr2 and Ctr1 might utilize a
similar mechanism to move copper across distinct subcellular
compartments. Both Ctr1 and Ctr2 possess conserved methio-
nine residues in the amino terminus as well as a Met-X3-Met
motif within transmembrane domain two, which are essential
for the function of Ctr1 in high affinity copper import from the
plasma membrane (Figs. 1A and 4A). To determine whether
these conserved methionine residues are required for Ctr2
function, mutant alleles of CTR2 were tested for complemen-
tation of the respiratory-deficient phenotype of ctr2 cells in
the context of ctr1ctr3. The Ctr2 amino terminus contains
two methionine residues, Met-59 and Met-61, that are 22 and
20 residues upstream of the first transmembrane domain, re-
spectively. CTR2 mutant alleles with either single alanine
mutations (M59A or M61A) or a double mutation
(M59A,M61A) were transformed into the ctr1ctr3ctr2 tri-
ple mutant strain and grown on YPEG media. As seen in Fig.
4B, both single mutant alleles (M59A and M61A) still comple-2 A. Chang, personal communication.
FIG. 2. Ctr2 is localized to the vacuole membrane. A, the ctr1ctr3ctr2 strain was transformed with p416GPD-CTR2-GFP and grown to
exponential phase. Cells were visualized by fluorescence microscopy to see the whole cell (DIC), Ctr2-GFP fluorescence (GFP), or the fluorescent
vacuole membrane marker FM4-64 (FM4-64). The vacuole is seen as an indentation in the DIC panels on the left. B, the same cells as in A were
spheroplasted, permeabilized, and fractionated on a discontinuous Ficoll density gradient. Samples from whole cell extracts (WCE), the top layer
(0%), and each interface of the gradient (0/4, 4/8, and 8/15% Ficoll) were collected and separated by SDS-PAGE. Ctr2-GFP was detected by
immunoblotting with anti-GFP antibody. Antibodies against alkaline phosphatase (Alp) and carboxypeptidase Y (Cpy) were used as vacuole
markers, and 3-phosphoglycerate kinase (Pgk) as a cytosolic control.
FIG. 3. Ctr2 mobilizes vacuole copper stores. A ctr2 strain was
transformed with the p416GPD vector or p416GPD-CTR2. Cells were
grown in selective media, and 1 h prior to harvesting cells, 20 M copper
was added. Vacuoles were isolated as described and 50 g of protein
from the vacuole samples were analyzed by ICP-MS. Data represent the
mean  S.D. of three experiments.
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mented the growth-defect phenotype. However, substitution of
both methionine residues with alanine (M59A,M61A) resulted
in a non-functional Ctr2 protein that could not rescue the
respiratory deficiency (Fig. 4B). Biochemical fractionation data
indicated that this non-functional Ctr2 protein retained proper
expression and localization (see Fig. 6A). Analogous to Ctr1
(37), changing both methionine residue substitutions in Ctr2 to
cysteine or histidine residues (M59C,M61C and M59H,M61H),
other potential copper ligands, restored growth with the addi-
tion of 20 M copper (data not shown), suggesting these methi-
onine residues are not only critical for function, but may po-
tentially coordinate copper ions at some point during the
copper mobilization process.
Mutations were also generated, singly (M148L or M152L)
and in combination (M148L,M152L), in the Met-X3-Met motif
in the second transmembrane domain of Ctr2. Each of the
mutant alleles, when expressed in the ctr1ctr3ctr2 strain
and seeded on a non-fermentable carbon source supplemented
with 20 M copper, resulted in a growth defect (Fig. 4B). This
was not because of a difference in localization between wild-
type and mutant Ctr2, as confirmed by indirect immunofluo-
rescence with the M148L,M152L mutant (data not shown).
Furthermore, the decrease in vacuolar copper levels observed
in cells expressing wild-type CTR2 was not observed when the
M148L,M152L mutant was expressed, consistent with its in-
ability to transport copper (data not shown). The functional
conservation of these methionine residues between Ctr1 and
Ctr2 supports the idea that, despite their localization to the
plasma membrane and vacuolar membrane, respectively, these
proteins transport copper across membranes via similar
mechanisms.
Based on both biochemical and genetic experiments, a cur-
rent model for Ctr1 function in copper transport across the
plasma membrane is consistent with Ctr1 forming a homomul-
timer, with evidence for homotrimers (31, 37). Given the role of
Ctr2 in vacuolar copper mobilization, the presence of conserved
FIG. 4. Genetic evidence suggests Ctr2 needs conserved methionine residues and homomultimerization for function. A, the
predicted topology of Ctr2 indicates the positions of the conserved methionines in the amino terminus (Met59-X-Met61) and second transmembrane
domain (Met148-X-X-X-Met152) that are mutated in the following experiments. B, the ctr1ctr3ctr2 strain expressing mutant alleles of CTR2 was
tested for function using the respiratory growth phenotype shown in Fig. 1B. Mutation of either of the conserved methionines (Met59 and Met61)
in the amino terminus of Ctr2 complements the phenotype (M59A and M61A), but mutation of both residues to alanine (M59A,M61A) does not.
For the conserved methionine residues in the transmembrane domain (Met148 and Met152), individual mutations (M148L and M152L) and the
double mutation (M148L,M152L) all result in a loss of Ctr2 function. C, co-expression of two different non-functional CTR2 alleles provides genetic
evidence for homomultimerization. Ctr2 methionine mutants (M59A,M61A and M148L,M152L) were subcloned into the p414GPD vector. The
ctr1ctr3ctr2 strain was co-transformed with p416GPD and p414GPD vectors alone, or wild-type Ctr2 (Ctr2wt), M59A,M61A, M148L,M152L,
Ctr2wt  M59A,M61A, Ctr2wt  M148L,M152L, or M59A,M61A  M148L,M152L. Cells were grown in SC-ura-trp media and tested for growth
on ethanol-glycerol media (YPEG). Cells were incubated for 3 days at 30 °C on SC-ura-trp and YPEG  100 M copper, and for 7 days on YPEG
and YPEG  15 M copper plates.
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and functionally important methionine residues, and a similar
predicted topology with three putative transmembrane do-
mains, we ascertained whether Ctr2 may also form obligatory
homomultimers. As shown in Fig. 2B, the Ctr2-GFP fusion
protein fractionates by SDS-PAGE as both unit length and
larger species consistent with higher-order multimers. A sim-
ilar observation was made for endogenous Ctr2 using poly-
clonal anti-Ctr2 antiserum, which detects polypeptide species
consistent with a monomer, dimer, and trimer (Fig. 6A). To test
whether this apparent homomultimerization occurs in vivo and
is important for Ctr2 function, we transformed the
ctr1ctr3ctr2 yeast strain with plasmids independently ex-
pressing the non-functional M59A,M61A or M148L,M152L al-
leles of CTR2, or both alleles, and tested for respiratory profi-
ciency. As shown in Fig. 4C, whereas independent expression of
either the M59A,M61A or M148L,M152L alleles did not restore
growth in this experiment, co-expression of the M59A,M61A
and M148L,M152L alleles rescued the copper-dependent res-
piratory deficiency observed in the ctr2 strain. In addition,
both of these Ctr2 mutations are recessive, as ctr1ctr3ctr2
cells co-expressing either M59A,M61A or M148L,M152L with
wild-type Ctr2 grow on copper-supplemented ethanol-glycerol
(Fig. 4C). Therefore, genetic evidence suggests that, similar to
Ctr1 in transporting copper across the plasma membrane, Ctr2
assembles as a homomultimer in the mobilization of copper
across the vacuolar membrane.
CTR2–1 Suppresses the ctr1ctr3 Mutant Phenotype by
Stimulating Copper Uptake at the Plasma Membrane—
Whereas Ctr2 shares structural features with the Ctr1 family
of high affinity plasma membrane copper transporters, and
defects in Ctr2 cause hyperaccumulation of vacuolar copper, it
is important to understand whether Ctr2 enhances the kinetics
of copper movement across membranes. To address this issue,
we selected for CTR2 variants capable of by-passing the re-
quirement for the Ctr1 and Ctr3 high affinity plasma mem-
brane copper transporters for copper acquisition, perhaps
through their mislocalization to the plasma membrane. The
CTR2 gene was randomly mutagenized by error-prone PCR, a
library of mutants introduced on plasmids into a ctr1ctr3
strain, and transformants identified that are capable of growth
on YPEG in the absence of added copper. By plasmid rescue
and DNA sequencing, four independent CTR2 mutant alleles
were found to suppress the loss of the high affinity plasma
membrane transporters (see Supplementary Materials). One
such suppressor allele, designated CTR2-1, confers robust
growth of the ctr1ctr3 strain on YPEG without copper sup-
plementation and was chosen for further investigation (Fig.
5A). CTR2-1 harbors two T3 A base substitutions, resulting in
FIG. 5. Identification of a mutant allele of CTR2 that stimulates copper accumulation and 64Cu uptake. A, PCR-based random
mutagenesis was used to construct a CTR2 mutant library. CTR2 mutant alleles were transformed into MPY17 (ctr1ctr3) and selected for
stimulation of copper uptake by growth on YPEG. CTR2-1 is one of four independent mutant alleles found that suppressed the ctr1ctr3
phenotype (see Supplemental Materials). B, CTR2-1 contains two base substitutions resulting in an amino acid substitution from tryptophan to
arginine at position seven, and a truncation of the final 16 amino acids (see Fig. 1A). Mutant alleles were cloned that contain either the amino
terminus mutation (W7R) or the carboxyl terminus truncation (C174stop), and these constructs were tested for their ability to suppress the
ctr1ctr3 respiratory defect. C, ctr1ctr3ctr2 cells expressing vector, wild-type CTR2, CTR2-1, or CTR1 were analyzed for cell-associated
copper by ICP-MS. D, 64Cu uptake was measured in the cells used for C.
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a Trp3 Arg amino acid substitution at position seven and the
generation of a stop codon at position 174, resulting in a trun-
cated form of the Ctr2 protein that lacks the carboxyl-terminal
16 amino acid residues (Fig. 1A). Each of the other three CTR2
suppressor alleles is truncated at or near this same codon, with
distinct amino acid substitutions at other positions within the
CTR2 open reading frame (see Supplementary Materials). In-
terestingly, dissection of the two mutations in CTR2-1 demon-
strates that while the carboxyl-terminal truncation is sufficient
for some of the ctr1ctr3 suppression activity, the two muta-
tions function together for maximal suppression (Fig. 5B). Fur-
ther analysis will be required to understand the basis for the
interactions between the two mutations underlying robust sup-
pression of ctr1ctr3 by CTR2-1.
CTR2 encodes a vacuolar membrane protein that functions
to mobilize copper from the vacuolar lumen to cytosolic copper
chaperones. To understand how the Ctr2-1 protein suppresses
the YPEG growth phenotype of the ctr1ctr3 strain, a plas-
mid bearing wild-type CTR2, the CTR2-1 allele, CTR1, or no
insert was transformed into a ctr1ctr3ctr2 strain and total
cell copper accumulation and the kinetics of 64Cu uptake were
measured. Copper accumulation measurements by ICP-MS
demonstrated that expression of CTR1 increased the accumu-
lation of copper 4-fold over that observed in cells transformed
with an empty vector. Interestingly, cells transformed with the
CTR2-1 allele exhibited an almost 2-fold increase in total cel-
lular copper accumulation over vector-transformed cells, dem-
onstrating that the Ctr2-1 protein functions to enhance copper
accumulation (Fig. 5C). Furthermore, as shown in Fig. 5D, the
rate of 64Cu uptake in cells expressing the CTR2-1 allele was
2-fold higher than either cells transformed with vector alone
or with a plasmid expressing wild-type CTR2 (Fig. 5D). The
increase was nearly abolished when experiments were per-
formed at 0 °C, suggesting that the increased uptake was not
because of general diffusion or nonspecific mechanisms (data
not shown). Note that overexpression of wild-type CTR2 stim-
ulates neither copper accumulation (Fig. 5C) nor the rate of
64Cu uptake (Fig. 5D). Taken together these results strongly
suggest that CTR2-1 by-passes the requirement for the CTR1
and CTR3 high affinity copper uptake proteins by enhancing
copper accumulation through facilitating copper uptake from
the exterior of the cell.
The ability of CTR2-1 to stimulate copper accumulation and
uptake implies a plasma membrane localization for the Ctr2-1
protein. Therefore, we investigated the subcellular localization
of Ctr2-1 by both biochemical fractionation and indirect immu-
nofluorescence microscopy. Spheroplast lysates were fraction-
ated on a Ficoll discontinuous step gradient followed by immu-
noblotting using the affinity purified polyclonal antiserum
directed against the presumptive Ctr2 cytosolic loop domain.
The data in Fig. 6A demonstrate that whereas Ctr2 and the
M59A,M61A mutant co-purify with vacuolar fractions, Ctr2-1
co-fractionated with both the vacuolar fraction (0/4% Ficoll)
and the plasma membrane fraction (4/8% Ficoll), as shown by
the presence of the Pma1 plasma membrane ATPase in the
latter fraction. Note that truncation of the carboxyl-terminal 16
residues of Ctr2-1 leads to a faster electrophoretic mobility as
compared with that of wild-type Ctr2, with both proteins dis-
playing species whose migration is consistent with monomers,
dimers, and homotrimers. Furthermore, as shown by indirect
immunofluorescence microscopy using the affinity purified an-
ti-Ctr2 antiserum, wild-type Ctr2 is found only on vacuolar
membranes (Fig. 6B). However, whereas much of the Ctr2-1
protein localizes to the vacuolar membrane, a significant signal
is seen on the plasma membrane. Taken together with the
copper accumulation and uptake data for CTR2-1, we conclude
that the ability of CTR2-1 to suppress the ctr1ctr3 mutant
growth defect on YPEG medium is attributable to partial lo-
calization to the plasma membrane. Importantly, the genera-
tion of a mislocalized Ctr2-1 protein has allowed a clear dem-
onstration that this protein stimulates the kinetics of copper
transport across membranes. Furthermore, these data support
the hypothesis that wild-type Ctr2 protein functions in copper
mobilization by facilitating the movement of copper from vac-
uolar luminal stores across the vacuole membrane and ulti-
mately to copper chaperones.
DISCUSSION
The ability to acquire metals from the environment, and
mobilize them from intracellular stores for signaling or as
co-factors to drive biochemical reactions, are important fea-
tures of metal homeostasis. Whereas much progress has been
made in understanding the mechanisms whereby mammalian
and yeast cells compartmentalize and mobilize calcium, zinc,
iron, and other metals, little information is available on how
copper stores are generated and utilized. Data presented here
strongly suggest that Ctr2 is a vacuolar membrane copper
transporter that functions to mobilize vacuolar copper stores.
Like the Ctr1 and Ctr3 high affinity copper transporters at the
plasma membrane, Ctr2 provides copper to all three of the
copper chaperone pathways.
Whereas earlier studies suggested that Ctr2 is a low affinity
copper transporter at the plasma membrane because of its
inability to suppress a ctr1ctr3 mutant when overexpressed
without added copper (32), work presented here and in other
studies (42, 43) demonstrates that Ctr2 resides on intracellular
membranes. Both fluorescence microscopy with a functional
Ctr2-GFP fusion and the use of polyclonal anti-Ctr2 antibody,
as well as biochemical fractionation data firmly establish a
vacuolar membrane localization for Ctr2. This localization does
not depend on the presence of Ctr1 and Ctr3 or the amount of
copper within a cell (data not shown), and indirect immunoflu-
orescence of a Ctr2 fusion protein in temperature-sensitive
yeast strains defective for receptor-mediated or fluid-phase
endocytosis suggests Ctr2 is not endocytosed from the plasma
membrane, but instead traffics directly to the vacuole from the
secretory pathway (42).
Despite the difference in subcellular location, the mecha-
nisms by which Ctr2 transports copper across the vacuole
membrane may nevertheless be similar to that of the Ctr1
family of plasma membrane transporters. Both biochemical
cross-linking experiments and in vivo trans-complementation
experiments strongly suggest that Ctr1 functions as a homo-
multimer, most likely a homotrimer (37). Our data demon-
strate that the methionine residues located in the amino ter-
minus and in the second transmembrane domain that are
important for Ctr1 function are conserved in Ctr2 and required
for its function. Indeed, co-expression of two distinct non-func-
tional alleles of CTR2 to reconstitute function in the delivery of
copper to the mitochondrial oxidative phosphorylation machin-
ery provides further genetic evidence in support of Ctr2 homo-
multimerization. The use of a common mechanism for copper
transport across two distinct membranes is analogous to the
copper transporters ATP7A and ATP7B in mammalian cells.
Whereas ATP7A pumps copper into the lumen of the secretory
apparatus for incorporation into proteins such as tyrosinase or
peptidylglycine -amidating monooxygenase, in response to
high intracellular copper concentrations ATP7A traffics to the
plasma membrane where it serves as a plasma membrane
copper efflux pump (53). In liver cells, ATP7A is not expressed,
and ATP7B delivers copper to ceruloplasmin or effluxes copper
into the bile via a mechanism of transport similar to ATP7A
(53). Whereas it is not yet clear whether Ctr1 and Ctr2 utilize
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a common copper transport mechanism, if this is the case it
would also suggest that Ctr2 would transport Cu(I) rather than
the oxidized Cu(II). The importance of the conserved methio-
nine residues in Ctr2, predicted to function as Cu(I) ligands for
Ctr1 (37), suggests that Ctr2 may transport Cu(I) and would
further suggest a requirement for a vacuolar metalloreductase
to function in concert with Ctr2. Current studies are underway
to further explore this hypothesis.
The yeast vacuole plays an important role in overall cellular
homeostasis for amino acids, phosphate, pH, and many other
ions and metabolites. Previous reports have demonstrated that
vacuoles represent an important organelle for the homeostatic
regulation of zinc and iron levels (15–18). Furthermore, mu-
tants in genes essential for normal vacuolar biogenesis have
been demonstrated to exhibit slow growth phenotypes on me-
dium containing elevated copper concentrations (16, 29), but
the precise role the vacuole plays in copper homeostasis is not
clear. One step toward a better understanding of the role of the
vacuole in copper homeostasis comes from work done in the
fission yeast S. pombe (54). Labbe´ and colleagues (54) found
that deletion of the ctr6 gene resulted in a significant decrease
in the activity of Cu,Zn-superoxide dismutase, and overexpres-
sion of ctr6 made the cells sensitive to high copper concentra-
tions. Interestingly, the copper sensitivity was not because of
an increase in copper uptake, in fact, 64Cu measurements in-
dicated a decrease in uptake when ctr6 is overexpressed. The
authors localized Ctr6 to the vacuole membrane and suggested,
based on the above observations, that this gene product func-
tions to mobilize vacuolar copper stores, which in turn results
in a reduction in the expression of the plasma membrane up-
take machinery through the down-regulation of the copper-
sensing transcription factor Cuf1. However, it is not clear
whether ctr6 function affects vacuolar copper levels and
whether Ctr6 directly transports copper.
In this work we have purified vacuoles and directly measured
vacuolar-associated copper. Our ICP-MS results provide direct
evidence for mobilization of vacuolar copper stores by Ctr2, as
there is approximately a 4-fold decrease in vacuolar-associated
copper levels when CTR2 is overexpressed (21 g of copper/g of
vacuole protein) compared with a ctr2 mutant (78 g of cop-
per/g of vacuole protein). Quantification of vacuolar iron and zinc
under these conditions in our vacuole purification suggest the
amounts of iron and zinc per g of vacuole-associated protein are
higher than the amounts of copper (5- and 45-fold, respectively)
and do not directly depend on the activity of Ctr2 (data not
shown). However, these metal levels will obviously fluctuate de-
pending on the cellular demand for ametal ion at a given time, as
well as the extracellular metal concentrations and the expression
of vacuolar metal importers and exporters. Whereas both the
vacuole importers and exporters for iron and zinc have been
identified (22–28), the protein or protein complex responsible for
import of copper into the vacuole has not yet been identified.
FIG. 6. Ctr2-1 is partially mislocalized to the plasma membrane. A, ctr2 cells expressing vector, wild-type Ctr2, Ctr2 M59A,M61A, or
Ctr2-1 were grown to exponential phase, and vacuoles were isolated and analyzed by immunoblotting as described in the legend to Fig. 2B, except
Ctr2 was detected by an anti-Ctr2 antibody. Markers against the plasma membrane (Pma1), vacuole (Alp), and cytosol (Pgk) were used. B,
ctr1ctr3ctr2 cells expressing vector or CTR2-1 were grown to exponential phase and then fixed by the addition of 4% formaldehyde to the
growth media, spheroplasted, and adhered to polylysine-coated slides. Cells were permeabilized with 0.1% SDS and then incubated with primary
antibody, followed by fluorescein isothiocyanate-conjugated secondary antibody. Cells were viewed by fluorescence microscopy.
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Because of its partial mislocalization, the mutant CTR2 al-
lele generated here may provide some insight into the sorting
mechanism required for wild-type Ctr2 to traffic to the vacuole,
whereas two other proteins relatively similar in structure and
function (Ctr1 and Ctr3) traffic to the plasma membrane.
Ctr2-1 contains a Trp 3 Arg substitution at amino acid posi-
tion 7, as well as a truncation of the carboxyl-terminal 16
amino acid residues. All four of the CTR2 mutant alleles found
to suppress the ctr1ctr3 mutant phenotype by selection on
YPEG media have truncations of the carboxyl-terminal resi-
dues immediately following the third transmembrane domain
(see Supplementary Materials). However, each of these mutant
alleles also contains at least one other amino acid substitution
at some point along the length of the protein. For Ctr2-1, the
Trp3 Arg substitution is required in concert with the carbox-
yl-terminal truncation for full suppression of the ctr1ctr3
respiratory deficiency. One possible explanation is that the
Trp 3 Arg substitution increases the activity of the protein,
and the carboxyl terminus of Ctr2 contains a vacuolar sorting
signal that is lost in Ctr2-1, resulting in its plasma membrane
localization. It is also possible that there are redundant sorting
signals in Ctr2. Studies in mammalian cells on the lysosomal
cystine exporter cystinosin have found that mutation of a car-
boxyl-terminal lysosomal sorting motif leads to partial mislo-
calization of this protein to the plasma membrane and a sub-
sequent stimulation of extracellular cystine uptake (55).
Interestingly, deletion of a portion of the third cytosolic loop of
cystinosin along with the mutation in the carboxyl terminus
leads to complete mislocalization of this protein (56). Further
studies must be done to clarify the effect of each of the muta-
tions in Ctr2-1 and identify the complex sorting signals of the
S. cerevisiae Ctr copper transport proteins that function at the
vacuole and on the plasma membrane.
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Supplementary Figure legends
Figure S1: Alignment of Ctr2 wild type and mutant amino acid sequences.  Four independently
generated Ctr2 mutants (Ctr2-1, -2, -3, and -4) were found to suppress the ctr1Dctr3D respiratory
defect. The amino acid sequence of wild type Ctr2 is given for reference, and amino acid
substitutions are shown in blue. The position of each of the three transmembrane domains (TM1,
2, and 3) is indicated by the horizontal lines. Biochemical and genetic analyses with Ctr2-1
indicate this mutant is partially mislocalized to the plasma membrane where it stimulates 64Cu
uptake, providing evidence that Ctr2 directly transports Cu.
Figure S2: Four CTR2 mutant alleles, but not wild type CTR2, can suppress the ctr1Dctr3D
respiratory defect. ctr1Dctr3D cells expressing an empty vector or plasmid-born CTR2, either
wild type or mutant, were seeded on the non-fermentable carbon source (YPEG) with or without
Cu supplementation.  While expression of wild type CTR2 restores growth in the presence of
exogenous Cu, all four mutant alleles (CTR2-1, CTR2-2, CTR2-3, and CTR2-4) promote growth
on unsupplemented YPEG.
Ctr2WT    MDDKKTWSTVTLRTFNQLVTSSLIGYSKKMDSMNHKMEGNAGHDHSDMHM
Ctr2-1    MDDKKTRSTVTLRTFNQLVTSSLIGYSKKMDSMNHKMEGNAGHDHSDMHM
Ctr2-2    MDDKKTWSTVTLGTFNQLVTSSLIGYSKKMDSMNHKMEGNAGHDHSDMHM
Ctr2-3    MDDKKTRSTVTLRTFNQLVTSSLIGYSKKMDSMNHKMEGNAGHDHSDMHM
Ctr2-4    MDDKKTWSTVTLRTFNQLVTSSLIGYSKKMDSMNHEMEGNAGHDHSDMHM
Ctr2WT    GDGDDTCSMNMLFSWSYKNTCVVFEWWHIKTLPGLILSCLAIFGLAYLYE
Ctr2-1    GDGDDTCSMNMLFSWSYKNTCVVFEWWHIKTLPGLILSCLAIFGLAYLYE
Ctr2-2    GDGDDTCSMNMLFSWSYKNTCVVFEWWHIKTLPGLILSCLAIFGLAYLYE
Ctr2-3    GDGDDTCSMNMLFSWSYKNTCVAFEWWHIKTLPGLILSCLAIFGLAYLYE
Ctr2-4    GDGDDTCSMNMLFSWSYKNTCVVFEWWHIKTLPGLILSCLAIFGLAYLYE
Ctr2WT    YLKYCVHKRQLSQRVLLPNRSLTKINQADKVSNSILYGLQVGFSFMLMLV
Ctr2-1    YLKYCVHKRQLSQRVLLPNRSLTKINQADKVSNSILYGLQVGFSFMLMLV
Ctr2-2    YLKYCVHKRQLSQRVLLPNRSLTKINQADKVSNSILYGLQVGFSFMLMLV
Ctr2-3    YLKYCVHKRQLSQRVLLPNRSLSKINQADKVSNSILYGLQVGFSFMLMLV
Ctr2-4    YFKYCVHKRQLSQRVLLPNRSLAKINQADKVSNSILYGLQVGFSSMLMLV
Ctr2WT    FMTYNGWLMLAVVCGAIWGNYSWCTSYSPEIDDSSLACH
Ctr2-1    FMTYNGWLMLAVVCGAIWGNYSW
Ctr2-2    FMTYNGWLMFAVVCGAIWGNYSW
Ctr2-3    FMTYNGWLMLAVVCGAIWGNYSW
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